YS-001

N/A

Report date: 2024/01/08 16:42:56
NME

Base Information

Drug NameYS-001
Drug Alias NameYS-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMammalian target of Rapamycin (mTORC1) inhibitorsmTOR Complex 2 inhibitorsPhosphatidylinositol 3 kinase beta inhibitors +[6] 
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2Phosphatidylinositol 3 kinase beta +[6] 
Therapy Area/IndicationsSolid tumoursBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Pharmaceutical Factory
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Zerun New Drug Research and Development Co LtdSuzhou Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A